LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹8,961 Cr | ₹8,502 Cr | ₹9,265 Cr | ₹8,276 Cr | ₹8,436 Cr |
What is the latest Total Current Liabilities ratio of LUPIN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹8,961 Cr |
| Mar2024 | ₹8,502 Cr |
| Mar2023 | ₹9,265 Cr |
| Mar2022 | ₹8,276 Cr |
| Mar2021 | ₹8,436 Cr |
How is Total Current Liabilities of LUPIN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,961 Cr | 5.41 | |
| Mar2024 | ₹8,502 Cr | -8.24 | |
| Mar2023 | ₹9,265 Cr | 11.95 | |
| Mar2022 | ₹8,276 Cr | -1.89 | |
| Mar2021 | ₹8,436 Cr | - | |
Compare Total Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹105,640.1 Cr | 2.7% | 8.1% | 21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 2.7% |
8.1% |
21% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses